Acceptability of HIV Pre-Exposure Prophylaxis (PrEP) and Implementation Challenges Among Men Who Have Sex with Men in India: A Qualitative Investigation.
This qualitative study explored the acceptability of HIV pre-exposure prophylaxis (PrEP) among MSM in India, and identified facilitators and barriers to future PrEP uptake. In 2014, we conducted 10 focus groups (n=61) among a purposive sample of diverse MSM recruited through community-based organizations in Chennai and Mumbai, and 10 key informant interviews with community leaders and health care providers. Participants' mean age was 26.1 years (SD 4.8); 62% completed secondary education, and 42% engaged in sex work. No focus group participants had heard of PrEP, but once explained, most reported they would likely use it. PrEP was alternately perceived as a 'back-up plan', a condom substitute, or a burden with concurrent condom use. Facilitators were potential for covert use, sex without condoms, and anxiety-less sex. Potential barriers emerged around stigma associated with PrEP use, fear of disclosures to one's family, wife, or male steady partner, and being labeled as HIV-positive or promiscuous by peers. Preferences emerged for intermittent rather than daily PrEP use, injectable PrEP, and free or subsidized access through community organizations or government hospitals. Key informants expressed additional concerns about risk compensation, non-adherence, and impact on ART availability for treatment. Demonstration projects are needed in India to support PrEP implementation tailored for at-risk MSM. Educational interventions for MSM should address concerns about PrEP effectiveness, side effects, and mitigate risk compensation. Community engagement may facilitate broad acceptability and challenge stigma around PrEP use. Importantly, provision of free or subsidized PrEP is necessary to making implementation feasible among low socioeconomic status MSM in India.
1 Centre for Sexuality and Health Research and Policy (C-SHaRP) , Chennai, India .|2 The Humsafar Trust , Mumbai, India .
Venkatesan
V
Chakrapani
3 Factor-Inwentash Faculty of Social Work, University of Toronto , Toronto, Canada .
Peter A
PA
Newman
1 Centre for Sexuality and Health Research and Policy (C-SHaRP) , Chennai, India .
Murali
M
Shunmugam
2 The Humsafar Trust , Mumbai, India .
Shruta
S
Mengle
2 The Humsafar Trust , Mumbai, India .
Jarvis
J
Varghese
1 Centre for Sexuality and Health Research and Policy (C-SHaRP) , Chennai, India .
Ruban
R
Nelson
4 School of Health Systems Studies, Tata Institute of Social Sciences (TISS) , Mumbai, India .
Shalini
S
Bharat
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D017280:Condoms / Q000706:statistics & numerical data; D017144:Focus Groups; D015658:HIV Infections / Q000188:drug therapy* / Q000523:psychology; D007722:Health Knowledge, Attitudes, Practice; D018451:Homosexuality, Male / Q000523:psychology* / Q000706:statistics & numerical data; D006801:Humans; D007407:Interviews as Topic; D008297:Male; D008875:Middle Aged; D010342:Patient Acceptance of Health Care / Q000208:ethnology / Q000706:statistics & numerical data*; D065129:Pre-Exposure Prophylaxis; D036301:Qualitative Research; D012747:Sexual Partners; D057545:Social Stigma; D014505:Urban Population
D019380:Anti-HIV Agents